Icosavax, Inc.·4

Jun 14, 7:48 PM ET

Khan Amin 4

4 · Icosavax, Inc. · Filed Jun 14, 2023

Insider Transaction Report

Form 4
Period: 2023-06-12
Khan Amin
EVP, Head of Research & Dev.
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-12+180,000180,000 total
    Exercise: $10.16Exp: 2033-06-11Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option will vest on June 12, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION